Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy

European Journal of Cancer

Volumn 46, Issue 18, 2010, Pages 3219-3232

  Houssami, Nehmat ^a   MacAskill, Petra ^a   Marinovich, M Luke ^a   Dixon, J Michael ^b   Irwig, Les ^a   Brennan, Meagan E ^a   Solin, Lawrence J ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

Breast conserving therapy; Invasive breast cancer; Local recurrence; Meta analysis; Radiation therapy; Surgical margins; Surgical oncology

Indexed keywords

ADJUVANT THERAPY; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; HORMONAL THERAPY; HUMAN; LOGISTIC REGRESSION ANALYSIS; META ANALYSIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; SYSTEMATIC REVIEW; TREND STUDY;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78649632377     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.07.043     Document Type: Article

References (74)

1. U. Veronesi, N. Cascinelli, and L. Mariani Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer New Engl J Med 347 2002 1227 1232
2. B. Fisher, S. Anderson, and J. Bryant Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer New Engl J Med 347 2002 1233 1241
3. J.A. Van Dongen, A.C. Voogd, and I.S. Fentiman Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial J Natl Cancer Inst 92 2000 1143 1150
4. M.M. Poggi, D.N. Danforth, and L.C. Sciuto Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial Cancer 98 2003 697 702
5. M. Blichert-Toft, C. Rose, and J.A. Andersen Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group J Natl Cancer Inst Monographs 11 1992 19 25
6. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2005 2087 2106
7. L.A. Newman, and H.M. Kuerer Advances in breast conservation therapy J Clin Oncol 23 2005 1685 1697
8. M. Morrow, E.A. Strom, and L.W. Bassett Standard for breast conservation therapy in the management of invasive breast carcinoma CA: Cancer J Clin 52 2002 277 300 (Pubitemid 35345499)
9. S.K. Al-Ghazal, L. Fallowfield, and R.W. Blamey Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction Eur J Cancer 36 2000 1938 1943
10. S.E. Singletary Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy Am J Surg 184 2002 383 393
11. R.W. Carlson, D.C. Allred, and B.O. Anderson Breast cancer. Clinical practice guidelines in oncology J Natl Comprehens Cancer Network 7 2009 122 192
12. G.F. Schwartz, U. Veronesi, and K.B. Clough Consensus conference on breast conservation J Am Coll Surg 203 2006 198 207
13. M. Morrow Margins in breast-conserving therapy: have we lost sight of the big picture? Expert Rev Anticancer Therapy 8 2008 1193 1196
14. A. Luini, J. Rososchansky, and G. Gatti The surgical margin status after breast-conserving surgery: discussion of an open issue Breast Cancer Res Treat 113 2009 397 402
15. S. MacDonald, and A.G. Taghian Prognostic factors for local control after breast conservation: does margin status still matter? J Clin Oncol 27 2009 4929 4930
16. G. Zavagno, E. Goldin, and R. Mencarelli Role of resection margins in patients treated with breast conservation surgery Cancer 112 2008 1923 1931
17. A. Taghian, M. Mohiuddin, R. Jagsi, S. Goldberg, E. Ceilley, and S. Powell Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey Ann Surg 241 2005 629 639
18. G. Sakamoto, H. Inaji, and F. Akiyama General rules for clinical and pathological recording of breast cancer Breast Cancer 12 Suppl. 2005 27
19. N.S. Goldstein, L. Kestin, and F. Vicini Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy: a clinicopathologic study of 607 neoplasms from 583 patients Am J Clin Pathol 120 2003 500 527
20. A.C. Neuschatz, T. DiPetrillo, and H. Safaii Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy Cancer 97 2003 30 39
21. C.C. Park, M. Mitsumori, and A. Nixon Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence J Clin Oncol 18 2000 1668 1675
22. D.G. Altman Systematic reviews of evaluations of prognostic variables M. Egger, G.D. Smith, D.G. Altman, Systematic reviews in health care: meta-analysis in context 2nd ed. 2001 BMJ Publishing Group London 228 247
23. A. Randolph, H. Bucher, and W.S. Richardson G. Guyatt, D. Rennie, Users' guide to the medical literature. A manual for evidence-based clinical practice 2002 AMA Press Chicago 141 154
24. G. Freedman, B. Fowble, and A. Hanlon Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy Int J Radiat Oncol Biol Phys 44 1999 1005 1015
25. E. Obedian, and B. Haffty Negative margin status improves local control in conservatively managed breast cancer patients Cancer Journal from Scientific American 6 1999 28 33
26. E. Touboul, L. Buffat, and Y. Belkacemi Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer Int J Radiat Oncol Biol Phys 43 1999 25 38
27. M. Kokubo, M. Mitsumori, and S. Ishikura Results of breast-conserving therapy for early stage breast cancer: Kyoto university experiences Am J Clin Oncol Cancer Clin Trials 23 2000 499 505
28. A.C. Voogd, M. Nielsen, and J.L. Peterse Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials J Clin Oncol 19 2001 1688 1697
29. J. Horiguchi, Y. Koibuchi, and H. Takei Breast-conserving surgery following radiation therapy of 50 Gy in stages I and II carcinoma of the breast: the experience at one institute in Japan Oncol Rep 9 2002 1053 1057
30. N.Q. Mirza, G. Vlastos, and F. Meric Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy Ann Surg Oncol 9 2002 256 265
31. K. Karasawa, T. Obara, and T. Shimizu Outcome of breast-conserving therapy in the Tokyo Women's Medical University Breast Cancer Society experience Breast Cancer 10 2003 241 248
32. C.A. Perez Conservation therapy in T1-T2 breast cancer: past, current issues, and future challenges and opportunities Cancer J 9 2003 442 453
33. M.C. Smitt, K. Nowels, R.W. Carlson, and S.S. Jeffrey Predictors of reexcision findings and recurrence after breast conservation Int J Radiat Oncol Biol Phys 57 2003 979 985
34. R.J. Santiago, L. Wu, and E. Harris Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience Int J Radiat Oncol Biol Phys 58 2004 233 240
35. J.R. Bellon, S.E. Come, and R.S. Gelman Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial J Clin Oncol 23 2005 1934 1940
36. K. Karasawa, M. Mitsumori, and C. Yamauchi Treatment outcome of breast-conserving therapy in patients with positive or close resection margins: Japanese multi institute survey for radiation dose effect Breast Cancer 12 2005 91 98
37. C. Kunos, L. Latson, and B. Overmoyer Breast conservation surgery achieving > or =2 mm tumor-free margins results in decreased local-regional recurrence rates Breast J 12 2006 28 36
38. O. Vujovic, A. Cherian, and E. Yu The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and node-negative disease, with long term follow-up Int J Radiat Oncol Biol Phys 66 2006 687 690
39. M. Ewertz, M. Moe Kempel, and M. During Breast conserving treatment in Denmark, 1989-1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group Acta Oncol 47 2008 682 690
40. B. Kreike, A.A.M. Hart, and T. van de Velde Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up Int J Radiat Oncol Biol Phys 71 2008 1014 1021
41. P. Varghese, J.M. Gattuso, and A.I.H. Mostafa The role of radiotherapy in treating small early invasive breast cancer Eur J Surg Oncol 34 2008 369 376
42. G.M. Freedman, A.L. Hanlon, B.L. Fowble, P.R. Anderson, and N. Nicolaou Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation J Clin Oncol 20 2002 4015 4021
43. S.J. Schnitt, A. Abner, and R. Gelman The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy Cancer 74 1994 1746 1751
44. I. Gage, S.J. Schnitt, and A.J. Nixon Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy Cancer 78 1996 1921 1928
45. N. Cabioglu, K.K. Hunt, and T.A. Buchholz Improving local control with breast-conserving therapy: a 27-year single-institution experience Cancer 104 2005 20 29
46. J. Horiguchi, Y. Iino, and H. Takei Surgical margin and breast recurrence after breast-conserving therapy Oncol Rep 6 1999 135 138
47. D.E. Wazer, R.K. Schmidt-Ullrich, and R. Ruthazer Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed Int J Radiat Oncol Biol Phys 40 1998 851 858
48. M.C. Smitt, K.W. Nowels, and M.J. Zdeblick The importance of the lumpectomy surgical margin status in long-term results of breast conservation Cancer 76 1995 259 267
49. L.J. Solin, B.L. Fowble, D.J. Schultz, and R.L. Goodman The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer Int J Radiat Oncol Biol Phys 21 1991 279 287
50. M.E. Peterson, D.J. Schultz, C. Reynolds, and L.J. Solin Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: The University of Pennsylvania experience Int J Radiat Oncol Biol Phys 43 1999 1029 1035
51. A. Recht, S.E. Come, and I.C. Henderson The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer New Engl J Med 334 1996 1356 1361 (Pubitemid 26152714)
52. J. Borger, H. Kemperman, and A. Hart Risk factors in breast-conservation therapy J Clin Oncol 12 1994 653 660
53. V.R. Kini, J.R. White, and E.M. Horwitz Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting Cancer 82 1998 127 133
54. S.J. DiBiase, L.T. Komarnicky, D.E. Heron, G.F. Schwartz, and C.M. Mansfield Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy Int J Radiat Oncol Biol Phys 53 2002 680 686
55. P.I. Tartter, J. Kaplan, and I. Bleiweis Lumpectomy margins, reexcision, and local recurrence of breast cancer Am J Surg 179 2000 81 85
56. S.C. Renton, J.C. Gazet, H.T. Ford, C. Corbishley, and R. Sutcliffe The importance of the resection margin in conservative surgery for breast cancer Eur J Surg Oncol 22 1996 17 22
57. P.T. Truong, S.O. Jones, and H.A. Kader Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy Int J Radiat Oncol Biol Phys 73 2009 357 364
58. P.M. Poortmans, L. Collette, and J.C. Horiot Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial Radiother Oncol 90 2009 80 85
59. T.P. Pittinger, N.C. Maronian, and C.A. Poulter Importance of margin status in outcome of breast-conserving surgery for carcinoma Surgery 116 1994 605 609
60. T.K. Yau, I.S. Soong, and K. Chan Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. gallen risk categories Int J Radiat Oncol Biol Phys 68 2007 667 672
61. M.A. Bollet, B. Sigal-Zafrani, and V. Mazeau Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first Radiother Oncol 82 2007 272 280
62. K. Hardy, K. Fradette, R. Gheorghe, L. Lucman, and S. Latosinsky The impact of margin status on local recurrence following breast conserving therapy for invasive carcinoma in Manitoba J Surg Oncol 98 2008 399 402
63. H.F. Rauschecker, W. Sauerbrei, and W. Gatzemeier Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG) Eur J Cancer 34 1998 315 323
64. H.A. Jones, N. Antonini, and A.A. Hart Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial J Clin Oncol 27 2009 4939 4947
65. T. Yoshida, H. Takei, and M. Kurosumi Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer Breast 18 2009 238 243
66. M. Kaufmann, M. Morrow, G. von Minckwitz, J.R. Harris Biedenkopf Expert Panel Members Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel Cancer 116 2010 1184 1191
67. A.S. Coates, A. Keshaviah, and B. Thurlimann Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98 J Clin Oncol 25 2007 486 492
68. R.C. Coombes, E. Hall, and L.J. Gibson A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer New Engl J Med 350 2004 1081 1092 (Pubitemid 38298988)
69. E.H. Romond, E.A. Perez, and J. Bryant Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer New Engl J Med 353 2005 1673 1684
70. I. Smith, M. Procter, and R.D. Gelber 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial Lancet 369 2007 29 36
71. M.D. Lagios Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination Cancer 40 1977 1726 1734
72. R. Holland, S.H. Veling, M. Mravunac, and J.H. Hendriks Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery Cancer 56 1985 979 990
73. H. Pass, F.A. Vicini, and L.L. Kestin Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution Cancer 101 2004 713 720
74. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement 2009. PLoS Med 6(6), doi:10.1371/journal.pmed1000097.